Anwar, M
In DAPA-HF, at baseline, 94% of patients were treated with ACEi, ARB or angiotensin receptor-neprilysin inhibitor (ARNI, including sacubitril/valsartan 11%), 96% with beta-blocker, 71% with mineralocorticoid receptor antagonist (MRA), 93% with diuretic, and 26% had an implantable device (with defibrillator function)
When used as part of a complete performance or healing protocol , especially alongside peptides like CJC-1295 , or stacked with BPC-157 , TB-500 , or supportive supplements like ZMT , DHEA , and L-Glutamine , Ipamorelin may help unlock real gains in performance, physique, and recovery
Some studies report stable or slightly improved bone density with GLP-1 therapy, while others suggest potential decreases, particularly in the context of significant weight loss
Hollis, T.M., Kern, J.A., Enea, N.A